1)Vassallo R, Ryu JH, Colby TV, et al. Pulmonary Langerhans’-cell histiocytosis. N Engl J Med. 2000; 342: 1969-78
|
|
|
2)Tazi A. Adult pulmonary Langerhans’ cell histiocytosis. Eur Respir J. 2006; 27: 1272-85
|
|
|
3)Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet. 1987; 1: 208-9
|
|
|
4)Lichtenstein L. Histiocytosis X: integration of eosinophilic granuloma of bone, Lettere-Siwe disease, and Schüller-Christian disease as related manifestation of a single nosologic entity. AMA Arch Pathol. 1953; 56: 84-102
|
|
|
5)井上義一. ランゲルハンス細胞組織球症の病態と臨床:総括. 日サ会誌. 2009; 29: 95-7
|
|
|
6)Badalian-Very G, Vergilio JA, Degar BA. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010; 8: 1919–23
|
|
|
7)Badalian-Very G, Vergilio JA, Fleming M, et al. Pathogenesis of Langerhans cell histiocytosis. Annu Rev Pathol. 2013; 8: 1–20
|
|
|
8)Sahm F, Capper D, Preusser M, et al. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood. 2012; 120: e28-34
|
|
|
9)Gaensler EA, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlation in 502 patients. Ann Thorac Surg. 1980; 30: 411-26
|
|
|
10)Watanabe T, Tatsumi K, Hashimoto S, et al. Clinico-epidemiological features of pulmonary histiocytosis X. Intern Med. 2001; 40: 998-1003
|
|
|
11)Alston RD, Tatevossian RG, McNally RJ, et al. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Pediatric Blood Cancer. 2007; 48: 555-60
|
|
|
12)Vassallo R, Ryu JH, Schroeder DR, et al. Clinical outcomes of pulmonary Langerhans’-cell histiocytosis in adults. N Engl J Med. 2002; 346: 484-90
|
|
|
13)杉本親寿, 井上義一.肺ランゲルハンス細胞組織球症.呼吸.2011; 30: 57-62
|
|
|
14)藤本圭作,久保恵嗣.若年発症COPD(若年性肺気腫),肺ランゲルハンス細胞ヒスチオサイトーシス(ヒスチオサイトーシスX),肺胞低換気症候群に関する全国疫学調査.平成18年度厚生労働省科学研究費
|
|
|
15)井上義一,石井榮一,森本 哲,他.肺病変を中心としたランゲルハンス細胞組織球症全国調査(共同)(小児血液学会HLH/LCH委員会との共同調査)中間報告:病型と臓器分布,予後.厚生労働科学研究費補助金 難治性疾患克服研究事業 呼吸不全に関する調査研究 平成24年度研究報告書.2013 (in press)
|
|
|
16)Bernstrand C, Cederlund K, Ashtrom L, et al. Smoking preceded pulmonary involvement in adults with Langerhans cell histiocytosis diagnosed in childhood. Acta Paediatr. 2000; 89: 1389-92
|
|
|
17)Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am J Rrespir Crit Care Med. 2005; 172: 530-51
|
|
|
18)Coury F, Annels N, Rivollier A, et al. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med. 2008; 14: 81-7
|
|
|
19)Fleming MD, Pinkus JL, Alexander SW, et al. Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood. 2003; 101: 2473-5
|
|
|
20)浅本 仁,北市正則,長井苑子,他.我が国における肺好酸球性肉芽腫症—17症例についての臨床的分析—.日胸疾会誌.1955; 33: 1372-81
|
|
|
21)Delobbe A, Durieu J, Duhamel A, et al. Determinants of survival in pulmonary Langerhans’ cell granulomatosis (histiocytosis X). Groupe d’Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Eur Respir J. 1996; 9: 2002-6
|
|
|
22)Howarth DM, Gilchrist GS, Mullan BP, et al. Langerhans cell histiosytosis: diagnosis, natural history, management and outcome. Cancer. 1999; 85: 2278-90
|
|
|
23)Suri HS, Yi ES, Nowakowski GS, et al. Pulmonary langerhans cell histiocytosis. Orphanet J Rare Dis. 2012; 7: 16
|
|
|
24)Girschikofsky M, Arico M, Castillo D, et al. Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis. 2013; 8: 72
|
|
|
25)Kambouchner M, Basset F, Marchal J. et al. Tree-dimensional characterization of pathologic lesions in pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med. 2002; 166: 1483-90
|
|
|
26)Krajicek BJ, Ryu JH, Hartman TE, et al. Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis. Chest. 2009; 135: 1542-9
|
|
|
27)Webb RW, Muller NL. High-resolution CT of the lung. Philadelphia: Lippincott Williams & Wilkins; 2001. p.424
|
|
|